Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin.

Lymphoid tissues from 12 patients were diagnosed as reactive lymphoid hyperplasia, but surface immunoglobulin studies revealed monoclonal (single class) immunoglobulin staining patterns. Infectious, autoimmune, and immunodeficient conditions were diagnosed on the basis of histology and clinical features. Such surface immunoglobulin restriction has been used as an indicator of a neoplastic lymphoid proliferation, but the cases of these patients, in whom the histologic diagnosis was benign, emphasize the importance of a multiparameter approach to diagnosis. Although at the time of this report none of the patients still available to follow-up study have developed known lymphoid neoplasms, the possibility that monoclonal SIg patterns are a harbinger of neoplastic disease makes continuing follow-up of such patients important.
AuthorsN Levy, J Nelson, P Meyer, R J Lukes, J W Parker
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 80 Issue 3 Pg. 300-8 (Sep 1983) ISSN: 0002-9173 [Print] UNITED STATES
PMID6410903 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Receptors, Antigen, B-Cell
  • Adolescent
  • Adult
  • Aged
  • Arthritis, Rheumatoid (immunology)
  • Female
  • Humans
  • Hyperplasia
  • Immunoglobulin Heavy Chains (classification)
  • Immunoglobulin Light Chains (classification)
  • Lymph Nodes (pathology)
  • Lymphocytes (immunology)
  • Lymphoma (immunology)
  • Male
  • Middle Aged
  • Receptors, Antigen, B-Cell (classification)
  • Toxoplasmosis (immunology)
  • Virus Diseases (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: